Roopa Industries Ltd.
Snapshot View

14.99 ▼0%

23 July 2021, 04:00:00 P.M.

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.roopaindustries.com
Financial Indicators
Market Cap 11.79 Cr.
Earnings per share (EPS) 0.91 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 16.47 Trailing Twelve Months Ending 2021-03
Industry PE 35.17 Trailing Twelve Months Ending 2021-03
Book Value / Share 14.70 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.02 Calculated using Price: 14.99
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.79 Cr. 7,865,520 Shares
FaceValue 10
Company Profile

Roopa Industries is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The company is a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.              

Roopa Industries is a chemical industry, growing in terms of its turn-over & profit making and reliability & credibility. Proud suppliers to several prestigious companies and exports to Germany, Netherlands, Srilanka etc.

The facility of the company comprises of the plant and equipment to carry out versatile operations for various reactions and related processes with an aggregate capacity of 60 Kilo Litres supported by utilities to meet chilling requirements of up to -25 Deg C and heating requirements of 500 Deg C coupled with requisite vacuums up to even one Torr and distillations.

The company has successfully handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations.

Product range of the company includes:

  • Triphenyl Phosphine.
  • Liquid Bromine.
  • 1 Bromo 3 Chloro Propane.
  • Glucosamine HCl.
  • Glucosamine Sulphate Sodium chloride.
  • Glucosamine Sulphate Potassium chloride. .

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
-0.07%
1 Month
-0.40%
3 Month
+47.39%
6 Month
+35.66%
1 Year
+44.13%
2 Year
+68.24%
5 Year
+76.77%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 6.69 1.72 -21.14 1.88 1.96 2.07 5.63 5.97 3.51
Return on Capital Employed (%) 14.35 7.02 -4.35 9.25 10.06 10.27 6.44 8.63 8.67
Return on Assets (%) 3.02 0.79 -8.50 0.65 0.68 0.70 1.68 1.68 1.00

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 10 11 8 9 9 9 10 10 11
Non Curr. Liab. 4 3 4 4 6 8 11 10 9
Curr. Liab. 7 10 12 13 10 11 15 16 19
Minority Int.
Equity & Liab. 21 23 24 26 25 29 35 36 38
Non Curr. Assets 10 10 10 10 8 7 9 11 11
Curr. Assets 11 14 13 16 17 21 26 25 27
Misc. Exp. not W/O
Total Assets 21 23 24 26 25 29 35 36 38

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 33 32 29 31 31 30 19 30 28
Other Income 0 0 0 0 3 0 5 0 1
Total Income 33 32 29 31 34 30 24 30 29
Total Expenditure -30 -30 -29 -29 -31 -28 -22 -28 -26
PBIDT 3 2 0 2 2 2 2 3 3
Interest -1 -1 -1 -1 -1 -2 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items 0 0 0
PAT 1 0 -2 0 0 0 1 1 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 1 -1 1 1 1 -1 -5 4 2
Cash Fr. Inv. -1 -1 0 0 0 0 3 -2 1
Cash Fr. Finan. 0 1 0 0 -1 2 2 -2 -3
Net Change 0 -1 0 0 0 0 0 0 0
Cash & Cash Eqvt 1 1 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03
Public 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 14 Jul 2021
Intimation Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Half Year Ended On 31St March 2021.
Intimation of Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (listing obligations and disclosure requirements) Regulations 2015 for half year ended on 31st March 2021.
Wed, 14 Jul 2021
Shareholding for the Period Ended June 30 2021
Roopa Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Tue, 13 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended on 30th June 2021

Technical Scans View Details

Fri, 23 Jul 2021
Stock Outperforming Benchmark Index in both 1 Week and 3 Month Stock Outperforming Benchmark Index in both 1 Week and 3 Month
Stock Outperforming Sectoral Index in both 1 Week and 3 Month Stock Outperforming Sectoral Index in both 1 Week and 3 Month
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Strongly Outperforming Sectoral Index Strongly Outperforming Sectoral Index
Close Within 2 Year High Zone Close Within 2 Year High Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 166,513.85 696.75 +0.4%
Divi's Laboratories Ltd. 128,088.59 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. 90,175.51 5,408.05 -0.3%
Cipla Ltd. 76,510.04 953.25 +0.6%
Cadila Healthcare Ltd. 62,965.29 610.55 -0.7%
Aurobindo Pharma Ltd. 56,484.48 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. 56,291.69 3,940.15 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 57.34 696.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2021-03 64.55 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.21 5,408.05 -0.3%
Cipla Ltd. Consolidated 2021-03 31.81 953.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 29.51 610.55 -0.7%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.59 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 374.38 3,940.15 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.58 696.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2021-03 13.78 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.15 5,408.05 -0.3%
Cipla Ltd. Consolidated 2021-03 4.17 953.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.85 610.55 -0.7%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.58 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.25 3,940.15 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 696.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,408.05 -0.3%
Cipla Ltd. Consolidated 2020-03 0.18 953.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 610.55 -0.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 3,940.15 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 696.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,408.05 -0.3%
Cipla Ltd. Consolidated 2020-03 10.09 953.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 610.55 -0.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 3,940.15 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 696.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,408.05 -0.3%
Cipla Ltd. Consolidated 2020-03 12.53 953.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 610.55 -0.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 3,940.15 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 696.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,408.05 -0.3%
Cipla Ltd. Consolidated 2020-03 17,131.99 953.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 610.55 -0.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 3,940.15 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 696.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,868.60 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,408.05 -0.3%
Cipla Ltd. Consolidated 2020-03 1,546.98 953.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 610.55 -0.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 961.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 3,940.15 +0.6%